Accéder au contenu
Merck

Effects of Joint Lavage with Dimethylsulfoxide on LPS-Induced Synovitis in Horses-Clinical and Laboratorial Aspects.

Veterinary sciences (2020-05-06)
Eric Danilo Pauls Sotelo, Cynthia Prado Vendruscolo, Joice Fülber, Sarah Raphaela Torquato Seidel, Fernando Mosquera Jaramillo, Fernanda Rodrigues Agreste, Luís Cláudio Lopes Correia da Silva, Raquel Yvonne Arantes Baccarin
RÉSUMÉ

Several studies in human and equine medicine have produced controversial results regarding the role of dimethylsulfoxide (DMSO) as a therapeutic agent. This study aimed to evaluate the effect of joint lavage with different DMSO concentrations on biomarkers of synovial fluid inflammation and cartilage degradation in joints with lipopolysaccharide (LPS)-induced synovitis. Twenty-six tibiotarsal joints of 13 horses were randomly distributed into four groups (lactated Ringer's solution; 5% DMSO in lactated Ringer's; 10% DMSO in lactated Ringer's; and sham). All animals were evaluated for the presence of lameness, and synovial fluid analyses were performed at 0 h, 1 h, 8 h, 24 h, and 48 h (T0, T1, T8, T24, and T48, respectively). The white blood cell counts (WBC), total protein (TP), urea, prostaglandin E2 (PGE2), interleukin (IL)-1β, IL-6, IL-10, tumor necrosis factor-α (TNF-α), hyaluronic acid (HA), and chondroitin sulfate (CS) concentrations were measured. The WBC counts and PGE2, IL-1β, IL-6, and TP concentrations increased in all groups at T8 compared to baseline values (p<0.05). At T48, only the 5% DMSO and 10% DMSO groups showed a significant decrease in WBC counts (p<0.05). Furthermore, the 10% DMSO group had lower concentrations of PGE2 and IL-1β at T48 than at T8 (p<0.05) and presented lower IL-6 levels than the5% DMSO and lactated Ringer's groups at T24. All groups showed an increase in CS concentration after LPS-induced synovitis. Joint lavage with 10% DMSO in lactated Ringer´s has anti-inflammatory but not chondroprotective effects.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Lipopolysaccharides from Escherichia coli O55:B5, Ready Made solution, 1 mg/mL